| Literature DB >> 35329834 |
Clémence Gachet1,2, Manon Prat2, Christophe Burucoa2,3, Philippe Grivard1, Maxime Pichon2,3.
Abstract
Through sperm alteration, semen microbiota tend to be recognized as a cause of infertility, but due to the limited number of studies focusing on this ecological niche, this hypothesis remains controversial. This study aimed to characterize and compare the bacterial communities of sperm samples from patients undergoing couple infertility treatment at the time of diagnosis. The study was prospective (September 2019 to March 2020), monocentric, and focused on alterations of spermatic parameters: count, motility, and morphology. After the amplification of the 16S rDNA (V1 to V3), libraries (n = 91, including 53 patients with abnormalities) were sequenced using the MiSeq platform (Illumina). After quality control processing using a homemade pipeline (QIIME2 modules), the main genera were: Prevotella, Finegoldia, Pseudomonas, Peptinophilus, Streptococcus, Anaerococcus and Corynebacterium. Restricted diversity was observed in samples from patients with abnormal sperm morphology (α-diversity, p < 0.05), whereas diversity increased in patients with an abnormal sperm count (β-diversity, p < 0.05). The enrichment of the genus Prevotella and Haemophilus was observed in negative sperm culture samples and samples with abnormal counts, respectively (p < 0.05). Microbiota differed in their composition according to sperm parameters. Finally, this work highlights the need for the optimization of the management of couples undergoing infertility treatment, possibly by modulating the genital microbiome.Entities:
Keywords: high-throughput sequencing; infertility; microbiome; omics; spermatozoa
Year: 2022 PMID: 35329834 PMCID: PMC8952859 DOI: 10.3390/jcm11061505
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flow chart of the study population. ART = assisted reproduction technique.
Patients’ baseline characteristics according to sperm parameters: motility, sperm count, and morphology. No statistical association could be observed between sperm parameters and clinical characteristics in the present cohort (p > 0.05).
| Clinical Characteristic | Motility | Sperm Count | Morphology | |||
|---|---|---|---|---|---|---|
| Motility | Motility | Sperm Count ≤ 39 Millions per Ejaculate ( | Sperm Count | Normal Morphology < 4% ( | Normal Morphology ≥ 4% ( | |
|
| 32 | 34.5 | 33 | 33 | 33.5 | 33 |
|
| 4 | 4 | 4 | 4 | 4 | 4 |
|
| 3.2 | 3.9 | 3.4 | 4 | 3.3 | 3.9 |
|
| 7/5/15 | 21/14/19 | 5/3/8 | 23/16/26 | 13/5/15 | 15/14/19 |
|
| 5 | 17 | 2 | 20 | 7 | 15 |
Figure 2Comparison of alpha diversities, determined with different indexes ((A) Chao1; (B) Shannon; (C) FaithPD) according to the “morphology” parameter. The comparison between groups with abnormal vs. normal morphology demonstrated significant difference (* p < 0.05).
Comparison of beta diversities, determined with different estimated indices (Bray–Curtis and weighted UniFrac indices) according to sperm parameters (* p < 0.05).
| Bray–Curtis Index | Unifrac Weighted Index | ||||
|---|---|---|---|---|---|
| Pseudo-F | Pseudo-F | ||||
|
| ≤39 vs. >39 | 3.05 | 0.022 * | 3.71 | 0.025 * |
|
| <32% vs. ≥32% | 1.73 | 0.098 | 2.61 | 0.074 |
|
| <4% vs. ≥4% | 0.80 | 0.508 | 0.59 | 0.585 |
Figure 3Comparison of beta diversities, determined with different indexes ((A–C): Bray–Curtis indexes and (D–F): Unifrac weighted indexes) according to the “Morphology” (A,D); “sperm count” (B,E), and “motility” (C,F) parameters. The comparison between groups with abnormal vs. normal sperm count demonstrated significant difference (* p < 0.05).
Main results of previous studies describing semen microbiota depending on semen biological parameters. CASA = computer-assisted semen analysis.
| Studies | Weng et al., 2014 [ | Baud et al., 2019 [ | Hou et al., 2013 [ |
|---|---|---|---|
|
| 36 normal semen parameters, 60 men with semen abnormalities | 26 normal semen parameters, 68 men with semen abnormalities | 19 healthy sperm donors, 58 men with semen abnormalities |
|
| MiSeq system (Illumina) | MiSeq system (Illumina) | Roche 454 GS-FLX (Roche-454 Life Sciences) Pyrosequencing |
|
| V4 16S rRNA gene | V1–V2 16S rRNA gene | V1–V2 16S rRNA gene |
|
| Volume, mobility, count, morphology, anti-sperm antibody, leucocytes, and CASA | Count, mobility, and morphology | Volume, mobility, and count |
|
| |||
|
| 6 groups characterized by high proportion of same species, but none predominant | ||
|
| G2 associated with normal semen parameters; G1 and G3 associated with abnormal semen parameters | No clusters were associated with semen parameters |